Borregaard’s operating revenues were NOK 1,799 million (NOK 1,949 million)2 in the 3rd quarter of 2025. EBITDA1 was NOK 440 million (NOK 524 million). The result in BioSolutions increased while BioMaterials and Fine Chemicals had lower results compared with the 3rd quarter of 2024. The reduced EBITDA1 was due to lower bioethanol prices and the temporary disruption in cellulose production at the Sarpsborg site. The negative impact from this disruption amounts to approximately NOK 40 million. The improvement ...

Financial Performance - Operating revenues increased to NOK 2,045 million in Q2 2025, up from NOK 1,949 million in the same period last year [1] - EBITDA reached NOK 522 million, compared to NOK 510 million in the previous year [1] - Profit before tax was NOK 326 million, slightly up from NOK 322 million [2] - Earnings per share increased to NOK 2.56 from NOK 2.45 [2] Segment Performance - BioSolutions saw improved results driven by continued growth in sales to agriculture [2][3] - BioMaterials experienced an increase in results due to higher sales prices, improved product mix, and increased sales volume, although this was partly offset by higher wood costs [2] - Fine Chemicals reported a weaker result primarily due to lower sales prices for bioethanol [2] Market Conditions - Positive net currency effects were noted across all areas [2] - The company’s President and CEO highlighted strong sales to agriculture and price increases for specialty cellulose as key drivers for improved results in BioSolutions and BioMaterials [3]

Core Insights - Borregaard reported an increase in operating revenues to NOK 2,036 million in Q1 2025, up from NOK 1,975 million in the same quarter last year [1] - EBITDA rose to NOK 511 million, compared to NOK 442 million in the previous year [1] - Profit before tax increased to NOK 319 million from NOK 261 million year-over-year [2] BioSolutions Performance - BioSolutions achieved an all-time high result, driven primarily by strong sales to the agriculture sector [2][3] - The specialization strategy of the company has shown resilience in challenging macroeconomic conditions, which is expected to be a key driver for future success [3] BioMaterials and Fine Chemicals Performance - For BioMaterials, higher sales prices were countered by lower sales volumes and increased costs, including wood costs [2] - Fine Chemicals experienced a weaker result primarily due to lower sales prices for bioethanol [2] Earnings Per Share - Earnings per share increased to NOK 2.52, up from NOK 2.01 in the corresponding quarter last year [2]